Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q1

3034.TEDINET S100OZXA
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥40.5bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥166.2bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥40.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.7bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥1.8bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.8bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥10.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.9bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.8bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥1.8bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.0bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥999m2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.0bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥98.1bnat 2022-06-30Cons.Assets
Total assets¥96.0bnat 2022-03-31Cons.Assets
Total assets¥101.4bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥53.7bnat 2022-06-30Cons.Liabilities
Total liabilities¥52.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥44.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥43.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥39.6bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥18.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥16.7bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥27.182022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥149.512021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.212021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio45.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.0%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥830m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥60m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥349m
—segment totalrevenue2022-04-01 → 2022-06-30¥40.6bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥40.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥77m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.5bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥80m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥80m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥770m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2021-04-01 → 2021-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2021-04-01 → 2021-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥15m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.3bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥3.2bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥3.2bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥64m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30¥311m
—segment totalrevenue2021-04-01 → 2021-06-30¥40.4bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥40.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥80m
—segment totalsegment profit2021-04-01 → 2021-06-30¥2.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 350
ItemContextValueUnit
Income before income taxesPrior1YTDDuration1837000000JPY
Income before income taxesCurrentYTDDuration1755000000JPY
Income taxes income taxesPrior1YTDDuration806000000JPY
Income taxes income taxesCurrentYTDDuration755000000JPY
Profit lossPrior1YTDDuration1031000000JPY
Profit lossCurrentYTDDuration999000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-1000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-2000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1033000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1001000000JPY
Profit lossPrior1YTDDuration1031000000JPY
Profit lossCurrentYTDDuration999000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-3000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration2000000JPY
Other comprehensive incomePrior1YTDDuration-3000000JPY
Other comprehensive incomeCurrentYTDDuration2000000JPY
Comprehensive incomePrior1YTDDuration1027000000JPY
Comprehensive incomeCurrentYTDDuration1002000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1029000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1004000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-1000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-2000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember37177000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember3173000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember40350000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration40350000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember15000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember64000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember80000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-80000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember37192000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember3238000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember40431000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-80000000JPY
Net salesPrior1YTDDuration40350000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember2286000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember311000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember2597000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-770000000JPY
Operating incomePrior1YTDDuration1827000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember37157000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember3392000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember40550000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration40550000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember17000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember60000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember77000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass